Full CoverageBreakthrough Alzheimer's drugs too pricey to be offered on NHS
By James Gallagher
All coverage
Not Over Yet: Eisai And Lilly To Appeal England’s ‘Flawed’ Refusal To Fund Leqembi And Kisunla
By Neena Brizmohun
U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service
By Andrew Joseph
Thousands of NHS patients denied breakthrough Alzheimer’s drugs
By Holly Bancroft
Breakthrough dementia drugs rejected AGAIN for use on NHS – as experts blast it ‘can’t keep up with scien...
By Sam Blanchard
NHS patients denied first drugs that treat Alzheimer’s
By Eleanor Hayward
NHS patients with Alzheimer's WON'T access 'miracle' drugs as watchdog says they are 'too expensive'
By Emily Cooper